Skip to content
HowShorted

Immunome, Inc. short interest in 2021

In 2021, Immunome, Inc.'s disclosed short interest ran from 2.22% of shares outstanding on 31 Mar 2021 to 2.00% on 31 Dec 2021, a change of -0.22 percentage points. The year's high was 2.78% on 31 Aug 2021 and its low 1.63% on 13 Aug 2021, averaging 2.07% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.70 days on 15 Jul 2021. Full history: Immunome, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Immunome, Inc. in 2021

2021 in figures

Start of year
2.22% (31 Mar 2021)
End of year
2.00% (31 Dec 2021)
Change
-0.22 pp
High
2.78% (31 Aug 2021)
Low
1.63% (13 Aug 2021)
Average
2.07%
Highest days to cover
5.70 (15 Jul 2021)
SEC filings marked
6

Every report in 2021

Immunome, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
31 Mar 20212.22%2.8010-K filed, results (8-K)
15 Apr 20211.80%3.74
30 Apr 20212.13%1.65
14 May 20212.18%3.1410-Q filed, results (8-K)
28 May 20212.28%2.43
15 Jun 20212.13%2.70
30 Jun 20211.96%2.22
15 Jul 20211.98%5.70
30 Jul 20211.91%1.00
13 Aug 20211.63%1.81
31 Aug 20212.78%3.9010-Q filed
15 Sep 20212.38%1.23
30 Sep 20212.20%1.16
15 Oct 20211.80%1.38
29 Oct 20211.98%2.16
15 Nov 20211.81%2.4510-Q filed
30 Nov 20211.81%1.50
15 Dec 20212.41%3.02
31 Dec 20212.00%3.14

See also: Immunome, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.